See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2019_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 482,425,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,411,000 |
| 3 | remainder_Assets | 16,331,000 |
| 4 | LiabilitiesCurrent | 114,205,000 |
| 5 | LiabilitiesNoncurrent | 375,021,000 |
| 6 | remainder_Liabilities | 811,000 |
| 7 | CostOfGoodsAndServicesSold | 5,996,113 |
| 8 | SellingGeneralAndAdministrativeExpense | 241,103,990 |
| 9 | ResearchAndDevelopmentExpense | 212,913,716 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 262,650,738 |
| 12 | remainder_NetIncome | -23,400,810 |
| 13 | remainder_ComprehensiveNetIncome | -1,473,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 509,167,000 |
| 1 | Liabilities | 490,037,000 |
| 2 | Expenses | 460,013,819 |
| 3 | Revenues | 262,650,738 |
| 4 | StockholdersEquity | 19,130,000 |
| 5 | NetIncome | -220,763,891 |
| 6 | ComprehensiveNetIncome | -221,500,391 |
| 7 | BaseVar | 873,371,184 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.360 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
